id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5119-0001,FDA,FDA-2019-N-5119,Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,Notice,Request for Comments,2019-12-04T05:00:00Z,2019,12,2019-12-04T05:00:00Z,2019-12-17T04:59:59Z,2019-12-17T02:04:01Z,2019-26222,0,0,09000064841e25a1